MAPK1 and vitiligo: However, an in vivo study report by Chauhan et al. [154] using a hydroquinone-induced vitiligo mouse model found that apigenin significantly prevented vitiligo by acting as an anti-inflammatory, increasing tyrosine, and reducing the expression of non-phosphorylated P38 mitogen-activated protein kinases (p38MAPK).